Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 2982 results

Clinical Trials / Jul 30, 2025

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria
Clinical Trials / Aug 18, 2026

Secukinumab Open Label Roll-over Extension Protocol
Clinical Trials / Jun 26, 2026

Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Clinical Trials / Jan 31, 2025

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Clinical Trials / May 16, 2024

Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
Press release / Sep 18, 2026

Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)

If approved, Cosentyx (secukinumab) will be first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica (PMR), providing new treatment option after steroids¹Recommendation based…
Expected currency impact
Novartis financial data
Report side effects or adverse events
Awards and recognition

‹ Previous page
1
…
16
17
18
19
20
21
22
…
299
› Next page